HLA-matched related donor hematopoietic stem cell transplantation is a suitable treatment in adolescents and adults with sickle cell disease: Comparison of myeloablative and non-myeloablative approaches.

Authors :: Dhedin N
Chevillon F
Castelle M
Lavoipière V
Vasseur L
Dalle JH
Joseph L
Beckerich F
Buchbinder N
Coman T
Garban F
Ferster A
Nguyen S
Boissel N
Arlet JB
Pondarre C
Source :: American journal of hematology [Am J Hematol] 2022 Sep; Vol. 97 (9), pp. E359-E362. Date of Electronic Publication: 2022 Jul 23.
Publication Year :: 2022

Subjects :: Adolescent
Adult
Humans
Myeloablative Agonists
Transplantation Conditioning
Anemia, Sickle Cell therapy
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation

Full Text Access

Tools